MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.010
-0.010 (-0.98%)
At close: Oct 9, 2026, 4:00 PM EDT
1.020
+0.010 (0.99%)
After-hours: Oct 9, 2026, 7:30 PM EDT
MaxCyte Revenue
MaxCyte had revenue of $7.27M in the quarter ending June 30, 2026, a decrease of -14.53%. This brings the company's revenue in the last twelve months to $31.05M, down -13.15% year-over-year. In the year 2025, MaxCyte had annual revenue of $33.03M, down -14.50%. That makes MaxCyte the 31,124th largest company in the world by revenue and 4,120th in the United States.
Revenue (ttm)
$31.05M
Revenue Growth
-13.15%
P/S Ratio
3.36
Revenue / Employee
$341,220
Employees
91
Market Cap
104.24M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.03M | -5.60M | -14.50% |
| Dec 31, 2024 | 38.63M | -2.66M | -6.44% |
| Dec 31, 2023 | 41.29M | -2.97M | -6.72% |
| Dec 31, 2022 | 44.26M | 10.37M | 30.59% |
| Dec 31, 2021 | 33.89M | 7.73M | 29.52% |
| Dec 31, 2020 | 26.17M | 4.55M | 21.04% |
| Dec 31, 2019 | 21.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.80M |
| Owlet | 114.41M |
| Pulmonx | 87.44M |
| LENSAR | 60.26M |
| Apyx Medical | 58.42M |
| electroCore | 36.97M |
| Nyxoah | 24.75M |
| Hyperfine | 16.54M |
MXCT News
- 18 days ago - MaxCyte appoints Kapileshwar as Chief Corporate Development Officer - TheFly
- 18 days ago - MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer - GlobeNewsWire
- 4 weeks ago - MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies - GlobeNewsWire
- 7 weeks ago - MaxCyte reports Q2 EPS (8c), consensus (9c) - TheFly
- 1 month ago - MaxCyte Earnings Call Transcript: Q2 2026 - Transcripts
- 1 month ago - MaxCyte Earnings release: Q2 2026 - Filings
- 1 month ago - MaxCyte Quarterly report: Q2 2026 - Filings